BurstDR Stimulation for Painful Diabetic Neuropathy

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04699734` - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy	N/A
Recruiting	`NCT05480228` - EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA	Phase 2
Recruiting	`NCT05476276` - EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy	Phase 2
Unknown status	`NCT01125215` - Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy	Phase 2/Phase 3
Not yet recruiting	`NCT05937984` - Treatment for Painful Diabetic Neuropathy	N/A
Recruiting	`NCT05080530` - Vitamin D and Painful Diabetic Neuropathy	N/A
Completed	`NCT04005287` - A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy	Phase 2
Recruiting	`NCT03331614` - An Evaluation of an SCCD on the Symptomatology of Painful DPN	N/A
Recruiting	`NCT03700528` - The Development of Contextual Cognitive Behavioural Approach to PDN	N/A
Recruiting	`NCT04689984` - The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient	Phase 2/Phase 3
Recruiting	`NCT04689958` - The Benefits of Vitamin D 5000 IU as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient	Phase 2/Phase 3
Recruiting	`NCT04689971` - The Benefits of Vitamin B Combination as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient	Phase 2/Phase 3
Completed	`NCT03749642` - Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy	Phase 2
Not yet recruiting	`NCT04087941` - Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial	Phase 2
Terminated	`NCT01129960` - Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain	Phase 3
Terminated	`NCT01056315` - A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y	Phase 2
Completed	`NCT00980746` - Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy	Phase 2
Completed	`NCT04786340` - A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy	Phase 2
Completed	`NCT03769675` - Quantitative Assessment of Painful Diabetic Peripheral Neuropathy After High Frequency Spinal Cord Stimulation	N/A
Completed	`NCT03755934` - Efficacy and Safety of MEDI7352 in Subjects With Painful Diabetic Neuropathy	Phase 2

NCT number	NCT05985291
Study type	Observational [Patient Registry]
Source	Aurora Health Care
Contact	Merve Buluk Figueira, MS
Phone	9204561551
Email	merve.figueira@aah.org
Status	Recruiting
Phase
Start date	July 3, 2023
Completion date	October 3, 2025

BurstDR Stimulation for Painful Diabetic Neuropathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms